These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11974427)

  • 1. Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region, Quebec.
    De Wals P; Allard MA; Guindon K; Mayrand L; Simard S; Black R
    Can Commun Dis Rep; 2002 Apr; 28(8):61-3. PubMed ID: 11974427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Public health: the control of meningococcal disease in Quebec].
    De Wals P; Duval B; De Serres G; Boulianne N; Dionne M
    Med Sci (Paris); 2003 Oct; 19(10):1011-5. PubMed ID: 14613016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    van Furth AM; Zaaijer HL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendation of vaccination against meningitis C in Cantabria].
    González de Aledo Linos A
    An Esp Pediatr; 2001 Oct; 55(4):379-80. PubMed ID: 11578550
    [No Abstract]   [Full Text] [Related]  

  • 5. Dutch consider following UK on vaccines after meningitis scare.
    Sheldon T
    BMJ; 2001 Sep; 323(7311):470. PubMed ID: 11532831
    [No Abstract]   [Full Text] [Related]  

  • 6. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
    Vogel G
    Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination against meningococcal meningitis outside the meningitis belt.
    Thapa SD; Koirala KD
    Lancet Infect Dis; 2011 Jun; 11(6):427. PubMed ID: 21616455
    [No Abstract]   [Full Text] [Related]  

  • 8. Leveraging community concerns regarding meningococcal disease to address racial and socioeconomic disparities in immunization coverage.
    Jones RC; Ramirez E; Gerber SI; Ritger KA; Morita JY
    J Public Health Manag Pract; 2011; 17(4):E3-8. PubMed ID: 21617399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    Zwart S; Sachs AP
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2253. PubMed ID: 11757253
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
    Galloway Y; Stehr-Green P; McNicholas A; O'Hallahan J
    Int J Epidemiol; 2009 Apr; 38(2):413-8. PubMed ID: 18988650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.
    Robbins JB; Schneerson R; Gotschlich EC; Mohammed I; Nasidi A; Chippaux JP; Bernardino L; Maiga MA
    Bull World Health Organ; 2003; 81(10):745-50; discussion 751-5. PubMed ID: 14758435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.
    Robbins JB; Schneerson R; Gotschlich EC
    Pediatr Infect Dis J; 2000 Oct; 19(10):945-53. PubMed ID: 11055594
    [No Abstract]   [Full Text] [Related]  

  • 15. [Life threatening bacterial meningitis. How it can be prevented, when it should be considered (interview by Dr. Thomas Meissner)].
    Dittmann S
    MMW Fortschr Med; 2007 Mar; 149(12):15. PubMed ID: 17674882
    [No Abstract]   [Full Text] [Related]  

  • 16. Protecting the world against meningitis: new recommendations from the CDC's advisory committee on immunization practices.
    Cyrus SS;
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S17-9. PubMed ID: 22086889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active hospital-based surveillance for meningococcal polysaccharide vaccine adverse events after an emergency mass immunization program, Edmonton, Alberta.
    Can Commun Dis Rep; 2005 Jun; 31(11):126-30. PubMed ID: 15940838
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the vaccination campaign in Cantabria 2 years of epidemiological evolution].
    González de Aledo A; García Merino J
    Rev Esp Salud Publica; 2000; 74(4):405-11. PubMed ID: 11031850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of tropical epidemics by vaccination--an update].
    Merlin M
    Med Trop (Mars); 2007 Aug; 67(4):351-6. PubMed ID: 17926793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.